Skip to main content
Caplight Logo









Cibus Therapeutics

Cibus Therapeutics

Private
Palo Alto, CaliforniaHealthcare & Life Scienceshttps://cibustherapeutics.com/

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Cibus Therapeutics is a clinical-stage biopharmaceutical company that develops targeted small-molecule therapies for inflammatory gastrointestinal diseases such as chronic pancreatitis and inflammatory bowel disease.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Patient Engagement

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biopharmaceuticalsmall-molecule therapygastrointestinal diseasechronic pancreatitisinflammatory bowel diseaseIBDdrug discoveryclinical-stage biotechbiotechdrug developmentAI-driven discoverytherapeutic pipelinedrug pipelinepreclinical research

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cibus Therapeutics Comparables

Compare Cibus Therapeutics with similar companies based on industry and business-model similarity.

Cibus Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Ensho Therapeutics
82%
Adiso Therapeutics
81%
Apini Therapeutics
79%

Cibus Therapeutics Funding Rounds

Historical fundraising activity

View Full Funding History

Access detailed round history, amounts raised, valuations, and investors.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 26, 2026

    Monthly visitors increased 51% MoM.

Cibus Therapeutics Filings

Explore SEC and related filing metadata, where available.

Cibus Therapeutics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Cibus Therapeutics's valuation, stock price, and market status.

Is Cibus Therapeutics a public or private company?

Cibus Therapeutics is a private company.

What is the current stock price of Cibus Therapeutics?

Cibus Therapeutics is a private company with no public stock price. No recent secondary market data is available.

How much is Cibus Therapeutics worth (valuation)?

Valuation information for Cibus Therapeutics is not publicly available.

Can I buy Cibus Therapeutics stock?

Cibus Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Cibus Therapeutics's last funding round?

Funding round information for Cibus Therapeutics is not publicly available.

Who are the main investors in Cibus Therapeutics?

Investor information for Cibus Therapeutics is not publicly disclosed.

Will Cibus Therapeutics IPO soon?

No public IPO plans have been announced for Cibus Therapeutics.

How can I track Cibus Therapeutics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Cibus Therapeutics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersPalo Alto, California
Employee Range2
Year Founded2021
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?